A Phase I, Double-blind, Randomized, Placebo-Controlled Study to Assess the Safety and Tolerability, and Pharmacokinetics of a Single Dose of AZD9742 in Healthy Elderly Male and Female Volunteers.
Phase of Trial: Phase I
Latest Information Update: 02 Aug 2010
At a glance
- Drugs AZD 9742 (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections
- Focus Adverse reactions
- Sponsors AstraZeneca
- 29 Jul 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 29 Jul 2010 Actual initiation date added to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 29 Jul 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.